Does intratracheal transplantation of alveolar type II cells reverse bleomycin-induced lung fibrosis?
This study demonstrates the potential role of alveolar type II cell transplantation in designing future therapies for lung fibrosis.
Fibrinolytic treatment appears to be an attractive nonsurgical alternative for prosthetic heart valve thrombosis, but because of the risk of cerebral embolism, its use should be reserved for tricuspid valve thrombosis or critically ill patients with mitral or aortic valve thrombosis. The use of a fibrinolytic agent in cases of small, nonobstructive paravalvular thrombosis demonstrated with transesophageal echocardiography needs further studies.